Nifty 50 dropped 2.3% across five sessions to close at 23,767.4 — still below its 200-day average and 9.7% below its 52-week high. The structural breadth gauge, the share of stocks above their 200-day average, slipped from 42.8% to 41.3% over the week, a modest but directionally clear move. The Stage-2 advancing cohort shrank by 30 names to 741 stocks, now just 33.2% of the market. The flow underneath confirms the direction: 64 stocks moved from Stage 2 into Stage 3 topping territory against only 27 moving the other way — a net loss of 37 names from the advancing pool in a single week.
How the week unfolded
Thursday's 1.1% index bounce on 17 July set a false tone. From Monday onward the tape deteriorated in a consistent pattern: the index fell on four of the five sessions, the fast short-term breadth gauge — the share of stocks above their 20-day average — collapsed from 41.9% on Monday to 31.1% by Thursday before a marginal recovery to 31.8% on Friday. That is not a consolidation; that is distribution. Wednesday was the ugliest session: decliners swamped advancers 1,651 to 560 and net new 52-week highs fell to just 27. By Thursday, net new highs had turned negative at -13 — more stocks hitting fresh lows than highs. Friday's slight improvement to a net +12 is a one-day data point inside a deteriorating trend, not a reversal signal. The regime has shifted from 'weak but recovering' to transition, and the near-term read is neutral-to-down for a second consecutive day.
What the screen surfaces — and what to make of it
The screener's job is to find Stage-2 setups regardless of the macro backdrop, and it has done that. Among the week's 1→2 transitions, IKIO Technologies cleared with a setup score of 8.8, Optiemus Infracom and MPS Ltd followed in Information Technology and Communication Services respectively, and Jupiter Life Line Hospitals entered from Health Care. On the sustained side, Kabra Extrusion Technik, RPG Life Sciences, Muthoot Microfin and Kapston Services all hold scores of 9.4 and have been in Stage 2 for five to ten weeks. Sky Gold and Diamonds has been advancing for 21 weeks. The pullback list includes RPG Life Sciences, Sky Gold and Diamonds, Tirupati Forge, Bharat Seats and Wanbury — names that have pulled back within an existing Stage-2 structure rather than breaking down.
| Stock | Sector | Move | Setup |
|---|---|---|---|
| IKIO Technologies Ltd | Industrials | 1→2 | 8.8 |
| Optiemus Infracom Ltd | Information Technology | 1→2 | 8.4 |
| MPS Ltd | Communication Services | 1→2 | 8.3 |
| Emami Paper Mills Ltd | Materials | 1→2 | 7.7 |
| Jupiter Life Line Hospitals Ltd | Health Care | 1→2 | 7.7 |
| Bluestone Jewellery and Lifestyle Ltd | Consumer Discretionary | 1→2 | 7.5 |
| iValue Infosolutions Ltd | Information Technology | 1→2 | 7.5 |
| TTK Prestige Ltd | Consumer Discretionary | 1→2 | 7.4 |
| Stock | Sector | Setup | RS |
|---|---|---|---|
| Kabra Extrusion Technik Ltd | Industrials | 9.4 | 82 |
| RPG Life Sciences Ltd | Health Care | 9.4 | 76 |
| Muthoot Microfin Ltd | Financials | 9.4 | 92 |
| Kapston Services Ltd | Industrials | 9.4 | 96 |
| Sky Gold and Diamonds Ltd | Consumer Discretionary | 9.4 | 97 |
| Gandhar Oil Refinery (INDIA) Ltd | Energy | 9.2 | 94 |
| MPS Ltd | Communication Services | 9.2 | 64 |
| Tirupati Forge Ltd | Consumer Discretionary | 9.2 | 94 |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Information Technology | +0.6% | +3.4% | -2.3% | 42 | 31% |
| Consumer Staples | +0.2% | +0.2% | -2.9% | 54 | 25% |
| Industrials | -0.1% | -3.0% | +6.4% | 69 | 36% |
| Energy | -0.1% | -0.9% | -2.6% | 57 | 29% |
| Utilities | -0.1% | -3.2% | -1.1% | 63 | 20% |
| Financials | -0.2% | -1.8% | -2.3% | 61 | 34% |
| Real Estate | -0.2% | +6.6% | +11.9% | 49 | 22% |
| Materials | -0.3% | -0.2% | +0.5% | 69 | 31% |
| Consumer Discretionary | -0.5% | +2.5% | +5.1% | 68 | 36% |
| Health Care | -0.7% | +2.1% | +13.6% | 73 | 52% |
| Communication Services | -1.1% | +1.7% | +7.9% | 65 | 18% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty -0.8%: breadth eroding, not a dip to buy
Decliners led 1,651 to 560, the fast breadth gauge has collapsed — this is distribution, not consolidation.
Nifty flat, internals stuck: range-bound, not recovering
Five sessions of chop, no breadth conviction, and more stocks leaving Stage 2 than entering it.
Nifty holds but internals keep slipping — treat it with suspicion
Fast breadth eroding, net Stage-2 flow negative, and Thursday's 1.1% index gain masked a 703-to-1,498 rout.